How it works
GABA is synthesised from glutamate, the brain's primary excitatory neurotransmitter, by the enzyme glutamate decarboxylase (GAD), which requires pyridoxal phosphate (vitamin B6) as a cofactor 13. This enzymatic step converts the brain's accelerator into its brake. Once released into the synapse, GABA binds to two distinct receptor classes: the ionotropic GABA-A receptor and the metabotropic GABA-B receptor, each operating through different timescales and molecular mechanisms.
GABA-A receptors are ligand-gated chloride channels 2. When GABA binds, the channel pore opens, permitting chloride ions to flow inward and hyperpolarising the neuron, raising the threshold for an action potential. This is phasic inhibition: rapid, synapse-specific, and brief. A second mode, tonic inhibition, involves low concentrations of ambient extracellular GABA persistently activating extrasynaptic GABA-A receptors that contain delta subunits 25. Tonic inhibition scales overall neuronal excitability across entire circuits rather than suppressing individual synaptic events. The GABA-A receptor is a heteropentamer assembled from 19 possible subunit types, producing hundreds of structurally distinct variants with different pharmacological profiles.
GABA-B receptors operate more slowly through G-protein-coupled signalling, inhibiting adenylyl cyclase and reducing presynaptic calcium conductance while activating postsynaptic potassium channels 3. This configuration gives GABA-B receptors a modulatory role: dampening transmitter release upstream and prolonging inhibitory potentials downstream. Together, the phasic, tonic, and GABA-B pathways allow a single amino acid to exert precise, multi-scale control over neural circuit dynamics.
Example
A competitive athlete preparing for a high-stakes event experiences acute anticipatory anxiety: elevated heart rate, racing thoughts, and difficulty settling into sleep the night before. A physician prescribes a short-course benzodiazepine, which binds to an allosteric site on GABA-A receptors, increasing chloride channel opening frequency without activating the receptor directly. Within the hour, neural inhibition increases, anxiety recedes, and sleep onset accelerates.
The benzodiazepine does not mimic GABA; it amplifies the effect of whatever GABA is already present, which illustrates how pharmacological leverage at an allosteric site can shift an entire arousal state.
Why it matters
Disrupted GABAergic signalling underlies an unusually broad clinical spectrum 34. Anxiety disorders, insomnia, epilepsy, and aspects of major depressive disorder all involve measurable deficits in inhibitory tone. This explains why the pharmacological agents developed to treat them, benzodiazepines, barbiturates, Z-drugs, and alcohol, converge on the same molecular target: they all potentiate GABA-A receptor activity. The commonality is not coincidence; it is the signature of a system so central to neural homeostasis that multiple drug classes independently found their way to it.
Beyond pathology, tonic GABA current shapes learning, memory consolidation, circadian rhythm, and arousal state in healthy individuals 5. Individual differences in extrasynaptic GABA tone contribute to cognitive variability that cannot be explained by genetic differences alone. For performance contexts, this means that behavioural interventions affecting GABAergic function, including sleep quality, exercise, and nutritional support, have downstream effects on the entire spectrum from anxiety threshold to working-memory capacity.
What does GABA do in the brain?+
GABA reduces the electrical activity of neurons. It binds to GABA-A and GABA-B receptors, triggering chloride influx or potassium channel activation that makes it harder for a neuron to fire. This inhibitory effect operates at both the single-synapse level (phasic inhibition) and across entire circuits (tonic inhibition), keeping neural activity within functional bounds.
Does oral GABA supplementation actually work?+
The evidence is modest. A systematic review of placebo-controlled trials found oral GABA supplementation can attenuate stress markers and modestly reduce sleep latency, but effect sizes are small. Whether ingested GABA crosses the blood-brain barrier or acts through peripheral gut-brain axis mechanisms remains unresolved.
How do benzodiazepines and alcohol affect GABA?+
Both potentiate GABA-A receptor activity by different mechanisms. Benzodiazepines bind to an allosteric site on the receptor complex, increasing the frequency of chloride channel opening in the presence of GABA. Alcohol has a similar net effect via multiple sites. Neither drug activates GABA receptors directly; both amplify the response to endogenous GABA.
What is the difference between GABA-A and GABA-B receptors?+
GABA-A is an ionotropic receptor: a ligand-gated chloride channel that produces fast, millisecond-scale inhibition when GABA binds. GABA-B is metabotropic: a G-protein-coupled receptor that acts on a slower timescale, modulating calcium and potassium channels and reducing neurotransmitter release from presynaptic terminals. Benzodiazepines act exclusively on GABA-A; baclofen targets GABA-B.
